FDA
approval
· 2021-08-25
FDA Approved: SKYTROFA — Original Application (Ascendis Pharma Endocrinology, Inc.)
Summary
FDA approves SKYTROFA (lonapegsomatropin-tcgD) from Ascendis Pharma Endocrinology as an original application. It provides a once-weekly growth hormone therapy f…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SKYTROFA (LONAPEGSOMATROPIN-TCGD)